PT Metro Healthcare Indonesia Tbk (CARE.JK)
IDR 174.0
(-1.69%)
IDR 174.0
(-1.69%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -7.68 Billion IDR | 52.5% |
| 2022 | 19.7 Billion IDR | -200.4% |
| 2021 | 31.39 Billion IDR | 16.59% |
| 2020 | 37.21 Billion IDR | 124.16% |
| 2019 | 5.83 Billion IDR | 487.14% |
| 2018 | 4.2 Billion IDR | -214.57% |
| 2017 | 2.52 Billion IDR | 1542.41% |
| 2016 | 7.06 Billion IDR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | -2.62 Billion IDR | -117.38% |
| 2024 Q1 | 1.8 Billion IDR | 64.86% |
| 2024 Q2 | -1.26 Billion IDR | -139.2% |
| 2023 Q4 | 1.49 Billion IDR | 106.52% |
| 2023 FY | - IDR | 52.5% |
| 2023 Q3 | -22.85 Billion IDR | -419.49% |
| 2023 Q2 | 7.15 Billion IDR | 165.29% |
| 2023 Q1 | -10.95 Billion IDR | -184.93% |
| 2022 FY | - IDR | -200.4% |
| 2022 Q3 | -6.18 Billion IDR | 32.89% |
| 2022 Q2 | -9.21 Billion IDR | -518.44% |
| 2022 Q1 | -1.48 Billion IDR | 58.01% |
| 2022 Q4 | 12.9 Billion IDR | 308.68% |
| 2021 Q1 | 14.29 Billion IDR | 348.4% |
| 2021 FY | - IDR | 16.59% |
| 2021 Q4 | -3.54 Billion IDR | -131.11% |
| 2021 Q3 | 11.4 Billion IDR | 16.49% |
| 2021 Q2 | 9.78 Billion IDR | -31.51% |
| 2020 Q1 | 3.13 Billion IDR | 12.02% |
| 2020 FY | - IDR | 124.16% |
| 2020 Q4 | 3.18 Billion IDR | -62.57% |
| 2020 Q3 | 8.51 Billion IDR | -17.01% |
| 2020 Q2 | 10.26 Billion IDR | 227.23% |
| 2019 Q2 | -723.02 Million IDR | 0.0% |
| 2019 Q1 | -723.02 Million IDR | 0.0% |
| 2019 FY | - IDR | 487.14% |
| 2019 Q4 | 2.79 Billion IDR | 177.15% |
| 2019 Q3 | -3.62 Billion IDR | -401.81% |
| 2018 FY | - IDR | -214.57% |
| 2017 FY | - IDR | 1542.41% |
| 2016 FY | - IDR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| PT Bundamedik Tbk | 223.9 Billion IDR | 103.43% |
| PT Medikaloka Hermina Tbk | 1584.42 Billion IDR | 100.485% |
| PT Mitra Keluarga Karyasehat Tbk | 1555.38 Billion IDR | 100.494% |
| PT Murni Sadar Tbk | 155.6 Billion IDR | 104.936% |
| PT Famon Awal Bros Sedaya Tbk | 443.01 Billion IDR | 101.734% |
| PT Royal Prima Tbk | 52.4 Billion IDR | 114.655% |
| PT Kedoya Adyaraya Tbk | 61.12 Billion IDR | 112.565% |
| PT Sarana Meditama Metropolitan Tbk | 323.18 Billion IDR | 102.376% |
| PT Siloam International Hospitals Tbk | 2692.46 Billion IDR | 100.285% |
| PT Sejahteraraya Anugrahjaya Tbk | 437.22 Billion IDR | 101.757% |